Investigation of rubella vaccine maked MICROGEN Federal State Company: study I trial

Experts of the RPU «Microgene», developed the new domestic medication for prevention of rubella — The rubella vaccine cultural live, on the basis of the vaccine strain RA 27/3. After the safety of vaccine had been proved on laboratory animals, the clinical trial had been activated on volunteers.The...

Full description

Saved in:
Bibliographic Details
Main Authors: A. N. Mironov, A. A. Tsaan, D. S. Bushmenkov, A. A. Romanova, Ye. S. Sidorenko, I. V. Feldblum
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2011-02-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/1316
Tags: Add Tag
No Tags, Be the first to tag this record!